AMTX vs STE · rev $77.2M vs P/E 25, rev $5.46B
Aemetis Inc (AMTX) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Aemetis Inc (AMTX) is a specialty chemicals company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported AMTX revenue for 2023-12-31 was $77.2M. Net income was -$46.4M. Revenue was up 174.6% from 2022-12-31 to 2023-12-31. AMTX currently screens at market cap $158.3M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
AMTX currently screens at market cap $158.3M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the AMTX and STE stock pages for the full models.
Not investment advice.